Objective : Type 1 diabetes mellitus (T1D) and dyslipidemia (DLP) increase the risk of cardiovascular disease (CVD). The objective of this study was to evaluate the progress and perspective of dyslipidemia in young T1D patients . Materials and Methods : The study was cross-sectional and descriptive design. Medical records of T1D patients were followed at an endocrinology service from 2008-2014. The collected data included gender, age, duration of T1D, body mass index (BMI), glycated hemoglobin (HbA1c), total cholesterol (TC), HDL, LDL and triglycerides (TG). Results : 126 T1D patients were recruited: 69 male (54.8%) and 57 female (45.2%) with a mean of age 16.4 (±0.18) and 16.5 (±0.18), respectively. Diabetes duration and baseline HbA1c were 14.82 (±2.11) and 8.68 (±1.21), respectively. The HbA1c (average range of HbA1c 6.5% to 10.7%) increased significantly while following five years by 2.9% (p < 0.001). The prevalence of overweight and obese teens was increasing from the 1st year to the following five years later. In contrast, the underweight and healthy subjects were decreasing for the same subsequent years. Means of HbA1c were significantly higher among overweight and obese categories throughout following years. All lipid profile revealed significant increase during five years follow-up study. The prevalence of risk TC/HDL ratio (< 4.1) gradually raised in the last year follow-up by 52.1% comparing to the baseline risk ratio (0.8%). The study of TC/HDL ratio with BMI categories revealed that average T1D patients had an ideal ratio (n = 97) in the 1st year measurement. After five years follow-up study, the frequency of ideal ratio declined among all categories in the same rate. Risk TC/HDL ratio in the last year of the study showed that average group had more risk ratio measurements (n = 47) in contrast to the 1st year measurement (n = 1). The significant positive correlations were reported between HbA1c and DLP as shown in figure (r2 = 0.85). HbA1c and BMI percentile analyses during long follow-up years werevery highly significant differences ( p < 0.0001) between the categories BMI in each year and from one year to another. Conclusion : Attention must be given to control DLP and other comorbidities among T1D adolescents to decrease diabetes macrovascular and microvascular complications.
KeywordsDiabetesDyslipidemiaDYSTID
Onkamo, P., et al. (1999) Worldwide Increase in Incidence of Type I Diabetes—The Analysis of the Data on Published Incidence Trends. Diabetologia, 42, 1395-1403. https://doi.org/10.1007/s001250051309
Feitosa, A.C., et al. (2013) Lipoprotein Metabolism in Patients with Type 1 Diabetes under Intensive Insulin Treatment. Lipids in Health and Disease, 12, 15. https://doi.org/10.1186/1476-511X-12-15
Atkinson, M.A., Eisenbarth, G.S. and Michels, A.W. (2014) Type 1 Diabetes. Lancet, 383, 69-82. https://doi.org/10.1016/S0140-6736(13)60591-7
Simsek, D.G., Aycan, Z., Ozen, S., Cetinkaya, S., Kara, C., et al. (2013) Diabetes Care, Glycemic Control, Complications and Concomitant Autoimmune Diseases in Children with Type 1 Diabetes in Turkey: A Multicenter Study. Journal of Clinical Research in Pediatric Endocrinology, 5, 20-26. https://doi.org/10.4274/Jcrpe.893
Laing, S.P., et al. (1999) The British Diabetic Association Cohort Study, II: Cause-Specific Mortality in Patients with Insulin-Treated Diabetes Mellitus. Diabetic Medicine, 16, 466-471. https://doi.org/10.1046/j.1464-5491.1999.00076.x
Schnell, O., et al. (2013) Type 1 Diabetes and Cardiovascular Disease. Cardiovascular Diabetology, 12, 156. https://doi.org/10.1186/1475-2840-12-156
Tomkin, G.H. (2008) Targets for Intervention in Dyslipidemia in Diabetes. Diabetes Care, 31(Suppl 2), S241-S248. https://doi.org/10.2337/dc08-s260
Maahs, D.M., Wadwa, R.P., Bishop, F., Daniels, S.R., Rewers, M., et al. (2008) Dyslipidemia in Youth with Diabetes: To Treat or Not to Treat? The Journal of Pediatrics, 153, 458-465. https://doi.org/10.1016/j.jpeds.2008.05.062
Schwab, K.O., et al. (2010) Characterization of 33 488 Children and Adolescents with Type 1 Diabetes Based on the Gender-Specific Increase of Cardiovascular Risk Factors. Pediatric Diabetes, 11, 357-363. https://doi.org/10.1111/j.1399-5448.2010.00665.x
Reh, C.M., et al. (2011) A Longitudinal Assessment of Lipids in Youth with Type 1 Diabetes. Pediatric Diabetes, 12, 365-371. https://doi.org/10.1111/j.1399-5448.2010.00733.x
NIH Medline Plus (2012) Cholesterol Levels: What You Need to Know. NIH Medline Plus, Bethesda, Maryland, 6-7.
Lemkes, B.A., et al. (2010) Hyperglycemia: A Prothrombotic Factor? Journal of Thrombosis and Haemostasis, 8, 1663-1669. https://doi.org/10.1111/j.1538-7836.2010.03910.x
Giuliano, I. and Caramelli, B. (2008) Dislipidemias na Infancia e na Adolescência. Pediatria, 29, 275-285.
Boni, A., Pugliese, C., Cláudio, C.C., Patin, R.V. and Oliveira, F.L.C. (2010) Vitaminas antioxidantes e Prevencao da Arteriosclerose na Infancia. Revista Paulista de Pediatria, 28, 373-380. https://doi.org/10.1590/S0103-05822010000400014
Alves, C., Veiga, S. and Souza, T. (2007) Dislipidemia e Risco de doenca Cardiovascular em Criancas e Adolescentes com Diabetes melito Tipo 1. Revista Paulista de Pediatria, 25, 82-89.
Pérez, A., Wagner, A.M., Carreras, G., Giménez, G., Sánchez-Quesada, J.L., Rigla, M., et al. (2000) Prevalence and Phenotypic Distribution of Dyslipidemia in Type 1 Diabetes Mellitus: Effect of Glycemic Control. Archives of Internal Medicine, 160, 2756-2762.
Wadwa, R.P., Kinney, G.L., Maahs, D.M., Snell-Bergeon, J., Hokanson, J.E., Garg, S.K., et al. (2005) Awareness and Treatment of Dyslipidemia in Young Adults with Type 1 Diabetes. Diabetes Care, 28, 51-56. https://doi.org/10.2337/diacare.28.5.1051
Minges, K.E., Whittemore, R. and Grey, M. (2013) Overweight and Obesity in Youth with Type 1 Diabetes. Annual Review of Nursing Research, 31, 47-69. https://doi.org/10.1891/0739-6686.31.47
Guy, J., Ogden, L., Wadwa, R.P., Hamman, R.F., Mayer-Davis, E.J., Liese, A.D., et al. (2009) Lipid and Lipoprotein Profiles in Youth with and without Type 1 Diabetes: the SEARCH for Diabetes in Youth Case-Control Study. Diabetes Care, 32, 416-420. https://doi.org/10.2337/dc08-1775
Arcanjo, C.L., Piccirillo, L.J., Machado, I.V., Jr. de Andrade, C.R.M., Clemente, E.L. and Gomes, M.B. (2005) Avaliacao de Dislipidemia e de índices Antropométricos em Pacientes com Diabetes Mellitus Tipo 1. Endocrinology and Metabolism Clinics of North America, 49, 951-958. https://doi.org/10.1590/s0004-27302005000600015
Giuffrida, F.M., Guedes, A.D., Rocco, E.R., Mory, D.B., Dualib, P., Matos, O.S., et al. (2012) Heterogeneous Behavior of Lipids according to HbA1c Levels Undermines the Plausibility of Metabolic Syndrome in Type 1 Diabetes: Data from a Nationwide Multicenter Survey. Cardiovascular Diabetology, 11, 156. https://doi.org/10.1186/1475-2840-11-156
Hong, Y.M. (2010) Atherosclerotic Cardiovascular Disease Beginning in Childhood. Korean Circulation Journal, 40, 1-9. https://doi.org/10.4070/kcj.2010.40.1.1
Marcovecchio, M.L., et al. (2009) Prevalence of Abnormal Lipid Profiles and the Relationship with the Development of Microalbuminuria in Adolescents with Type 1 Diabetes. Diabetes Care, 32, 658-663. https://doi.org/10.2337/dc08-1641
Soedamah-Muthu, S.S., et al. (2004) Risk Factors for Coronary Heart Disease in Type 1 Diabetic Patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care, 27, 530-537. https://doi.org/10.2337/diacare.27.2.530
Rodriguez, B.L., et al. (2006) Prevalence of Cardiovascular Disease Risk Factors in U.S. Children and Adolescents with Diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care, 29, 1891-1896. https://doi.org/10.2337/dc06-0310
Stampfer, M.J., et al. (1996) A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction. The Journal of the American Medical Association, 276, 882-888. https://doi.org/10.1001/jama.1996.03540110036029
Ridker, P.M., Stampfer, M.J. and Rifai, N. (2001) Novel Risk Factors for Systemic Atherosclerosis: A Comparison of C-Reactive Protein, Fibrinogen, Homocysteine, Lipoprotein(A), and Standard Cholesterol Screening as Predictors of Peripheral Arterial Disease. The Journal of the American Medical Association, 285, 2481-2485. https://doi.org/10.1001/jama.285.19.2481
Kinosian, B., Glick, H. and Garland, G. (1994) Cholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios. Annals of Internal Medicine, 121, 641-647. https://doi.org/10.7326/0003-4819-121-9-199411010-00002
Millan, J., et al. (2009) Lipoprotein Ratios: Physiological Significance and Clinical Usefulness in Cardiovascular Prevention. Vascular Health and Risk Management, 5, 757-765.
Liese, A.D., et al. (2011) Association of DASH Diet with Cardiovascular Risk Factors in Youth with Diabetes Mellitus: The SEARCH for Diabetes in Youth Study. Circulation, 123, 1410-1417.
Conway, B., et al. (2009) Adiposity and Mortality in Type 1 Diabetes. International Journal of Obesity, 33, 796-805.